缺陷的流动-迁移合导致遗传性出血外长膜瘤的动脉静脉形
Hyojin Park1, Jessica Furtado1, Mathilde Poulet1
1Cardiovascular Research Center, Department of Internal Medicine (H.P., J.F., M.P., M.C., S.Y., M.A.S., A.E.), Yale University School of Medicine, New Haven, CT.
Circulation
|June 29, 2021
概括
在血管发育中,激素受体类激酶1 (ALK1) 是至关重要的. 它的损失会损害内皮细胞的两极分化和迁移,导致遗传性出血端膜瘤的动脉静脉形.
科学领域:
- 心血管生物学
- 细胞生物学
- 发育生物学
背景情况:
- 激素受体样酶1 (ALK1) 是一个内皮受体,对心血管发育和病理学至关重要.
- 在ALK1的功能丧失突变导致遗传性出血端膜瘤2型,其特征是动脉静脉形.
- 根据血液流动,ALK1调节内皮细胞的偏离和迁移.
研究的目的:
- 研究ALK1在内皮细胞偏离和迁移中的作用.
- 阐明ALK1介导的流量反应的分子机制.
- 为了确定遗传性出血的治疗目标.
主要方法:
- 使用Cre线来删除特定内皮细胞子集中的Alk1.
- 在体内和体外评估内皮细胞偏振和迁移.
- 在Alk1缺乏细胞中分析了整合蛋白和YAP/TAZ信号通路.
主要成果:
- 通过毛细血管删除Alk1导致出生后视网膜的动脉静脉形.
- 缺失ALK1导致内皮细胞对血液流动的偏离受损.
- 在ALK1缺乏的细胞中观察到增加的整合蛋白信号和YAP/TAZ核转位.
- 抑制整合蛋白或YAP/TAZ信号,挽救流量迁移合并防止形.
结论:
- ALK1对于流动诱导的内皮细胞迁移至关重要.
- 流动-迁移合的丧失导致了继承性出血性脑膜瘤的动脉静脉形.
- 综合素- YAP/ TAZ信号抑制剂是遗传性出血性脑膜炎的潜在治疗点.
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
Mechanism of Angiogenesis
6.1K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.1K
Disorders of Hemostasis
1.5K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.5K


